08 February 2010, Monday, 16:49
author: Galya Nabieva
The collective of the Ufa’s enterprise “IMMUNOPREPARAT” (a daughter company of “NPO MICROGEN”) has finished January with very good production indices. The news-secretary of the enterprise Guzelle Usupova reports the plant has produced various immune-biological and pharmaceutical preparations for the sum of 147 million 629 thousand rubles. The manufacturing plan is executed by 116,5% and the capacity extension made 350,2%. The index of physical volume (in comparable prices of 2009) is 362,2%.
The enterprise is in the lead in the internal market of anti-flu vaccines. Every year the company successfully fulfills the public contract of Russian Ministry of health protection and social development on production of the popular Russian vaccine “GRIPPOL”. In 2009 the Bashkir specialists have issued about 21 million doses. This preparation was sent to the regions of the country for free immunization of adults and children within the frames of the federal goal-oriented program “Health”.
In May 2010 “IMMUNOPREPARAT” intends to start construction of a new workshop for production of anti-flu vaccines in accordance with the international standards. In opinion of the director of the company “MICROGEN” Makhamat Alsynbaev the modern autonomous mini-plant for production of anti-flu vaccines for the needs of Russian health system with the overall output up to 50 million doses annually will be erected in the capital of Bashkortostan. This very promising pharmaceutical project possesses high social and economic significance and specialists predict its high payback. Designing and launching of a new workshop is planned to realize jointly with the specialists from Czechia.